China Money Network
Login
Join

Chinese Biopharmaceutical Firm Junshi Biosciences Targets $414M IPO In Hong Kong

  • December 11, 2018 — 16:29 CST

This Data Is Locked!

This area is available only to Subscribers.

Chinese biopharmaceutical company Shanghai Junshi Biosciences Co. has filed for a US$414 million initial public offering in Hong Kong, according to a security filing released... [DATA LOCKED]

UNLOCK DATA

Follow the Money & Subscribe for Access to the Best Data and Intelligence on Chinese Venture Capital Deals

Join

Access Thousands of Data Points to Monitor Chinese Private Equity Deal Movement and Relationships

Already Have an Account?

Login
Related Topics:

Related Data: